Where our team of guest writers discuss what they think about the current NGP US Issues.
How analytical capabilities can empower pharmaceutical manufacturers with new ways to optimize revenue.
By David Blumberg
Now is the time for pharmaceutical manufacturers to invest in robust systems for calculating and reporting drug prices.
Regulatory compliance is, for most people, an afterthought at best when it comes
to evaluating products and services. You should think like your customers, says
Adrian Bowles.
Laboratory managers and IT professionals are under increasing pressure to improve efficiency, reduce costs, shorten time to market for new compounds, and improve regulatory compliance and data quality. With software technology, they can. But where does one begin? By Michael H. Elliott, CEO, Atrium Research